Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
16 03 2022
Historique:
entrez: 17 3 2022
pubmed: 18 3 2022
medline: 6 4 2022
Statut: epublish

Résumé

To explore the phenomenon of topical corticosteroid (TCS) phobia and comprehensively understand the factors driving TCS concerns, in particular pertaining to steroid addiction and withdrawal. Prospective qualitative study using 1:1 in-depth semistructured interviews and analysed using grounded theory. Patients with a prior experience of TCS use for a dermatological condition recruited from a tertiary academic dermatology clinic, or through word of mouth and online social media platforms. 26 participants encompassing those with positive, neutral and negative opinions towards TCS were interviewed. 13 reported having topical steroid addiction or withdrawal. The drivers of TCS concerns could be categorised into seven themes: attitudes towards TCS (comprising beliefs and knowledge about TCS), availability of alternatives, treatment inconvenience, personality, patient's ongoing evaluation of clinical response to TCS, doctor-patient relationship and healthcare-seeking behaviour. Of mention, patients placed high value and trust on their own experiences with TCS, such as their perceived experienced side effects. The doctor who failed to acknowledge the patient's opinions and instead emphasised the safety of TCS was often viewed as dismissive, resulting in a deteriorating patient-doctor relationship. Provision of knowledge and education is important but may be ineffective if the basis for TCS concern regarding safety is reasonable, or when the patient has a firmly established belief supporting his/her concern. In such instances, failure to acknowledge and respect the patient's decision to avoid TCS could worsen the doctor-patient relationship.

Identifiants

pubmed: 35296492
pii: bmjopen-2022-060867
doi: 10.1136/bmjopen-2022-060867
pmc: PMC8928312
doi:

Substances chimiques

Dermatologic Agents 0
Glucocorticoids 0
Steroids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e060867

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS One. 2013 Oct 16;8(10):e76493
pubmed: 24146878
Br J Dermatol. 2011 Oct;165(4):808-14
pubmed: 21671892
J Dermatolog Treat. 2017 Dec;28(8):722-725
pubmed: 28488449
Eur J Pain. 2012 Apr;16(4):592-9
pubmed: 22396087
Ann Fam Med. 2011 Mar-Apr;9(2):100-3
pubmed: 21403134
Br J Dermatol. 2017 Mar;176(3):759-764
pubmed: 27664969
J Am Acad Dermatol. 2020 Dec;83(6):1681-1687
pubmed: 32171815
Drugs Context. 2018 Dec 03;7:212547
pubmed: 30532792
Pediatr Dermatol. 2019 May;36(3):311-316
pubmed: 30882946
J Dermatolog Treat. 2019 May;30(3):245-250
pubmed: 30081700
JAMA Dermatol. 2017 Oct 1;153(10):1036-1042
pubmed: 28724128
Br J Dermatol. 2017 Jul;177(1):197-205
pubmed: 28301043
Front Immunol. 2019 Dec 03;10:2847
pubmed: 31849996
Fam Pract. 2002 Oct;19(5):476-83
pubmed: 12356698
Eur J Pain. 2012 Feb;16(2):239-46
pubmed: 22323376
JAMA Dermatol. 2019 May 1;155(5):585-593
pubmed: 30916723
J Dermatolog Treat. 2021 Aug 9;:1-8
pubmed: 34314298
Eur Psychol. 2019;24(1):7-25
pubmed: 31496632
J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e172-e174
pubmed: 27608366
Psychol Health. 2020 Mar;35(3):255-274
pubmed: 31340675
Med Care. 2002 Apr;40(4 Suppl):II40-44
pubmed: 12064580
J Am Acad Dermatol. 2020 Dec;83(6):e403-e404
pubmed: 32171809
Clin Drug Investig. 2021 Oct;41(10):835-842
pubmed: 34409577
Singapore Med J. 2020 Mar;61(3):149-153
pubmed: 32488277
Prim Care Companion CNS Disord. 2015 Oct 22;17(5):
pubmed: 26835164
J Dermatolog Treat. 2021 Aug;32(5):478-483
pubmed: 31610687
Br J Dermatol. 2018 Nov;179(5):1062-1071
pubmed: 29654699
J Dermatolog Treat. 2020 Sep;31(6):624-625
pubmed: 31418325
Allergy. 2017 Nov;72(11):1713-1719
pubmed: 28439896
World J Pediatr. 2012 Aug;8(3):263-7
pubmed: 22886202
Pain. 2015 Feb;156(2):215-219
pubmed: 25599441
J Am Acad Dermatol. 2016 Aug;75(2):410-419.e3
pubmed: 27177441
Eur J Psychol. 2018 Nov 30;14(4):880-896
pubmed: 30555591

Auteurs

Sean Tan (S)

Dermatology, National University Healthcare System, Singapore.

Phillip Phan (P)

Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins Carey Business School, Baltimore, Maryland, USA.
Medicine, National University of Singapore, Singapore.

Je Yin Law (JY)

Medicine, National University of Singapore, Singapore.

Ellie Choi (E)

Dermatology, National University Healthcare System, Singapore ellie_choi@nuhs.edu.sg.
Medicine, National University of Singapore, Singapore.

Nisha Suyien Chandran (NS)

Dermatology, National University Healthcare System, Singapore.
Medicine, National University of Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH